Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis.
AUTOR(ES)
Bénichou, B
RESUMO
Expression of class II major histocompatibility complex antigens in defective B-lymphoblastoid cell lines from patients with class II antigen deficiency and from in vitro mutants generated with the same phenotype was studied. By heterogenetic fusion experiments, at least three, and probably four, complementation groups were defined. Furthermore, clone 13 (a DR-, DP-, but DQ+ cell line) appeared to belong to the RJ2.2.5 complementation group, for which all other members are DR-, DP-, and also DQ-. Thus, it is hypothesized that the cell lines of this group lack the activity of a gene that can differentially regulate the DR/DP and the DQ promoters.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=51643Documentos Relacionados
- Reversion of a transcriptionally defective MHC class II-negative human B-cell mutant.
- Expression of HLA-DR antigen in human class II mutant B-cell lines by double infection with retrovirus vectors.
- Three distinct stages of B-cell defects in common varied immunodeficiency
- Three distinct stages of B-cell defects in common varied immunodeficiency.
- Two distinct genetic loci regulating class II gene expression are defective in human mutant and patient cell lines.
